AEM vs HL

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

HL presents a dichotomy between stellar operational growth and concerning valuation/sentiment metrics. While the Piotroski F-Score of 4/9 indicates stable financial health and the company boasts explosive YoY earnings growth (951.5%), the stock is trading at a significant premium to its Graham Number ($6.53) and Intrinsic Value ($14.46). This valuation stretch is compounded by a bearish technical trend (0/100) and aggressive insider selling by the CFO and General Counsel. Consequently, the strong fundamental growth is currently offset by overvaluation and negative internal sentiment.